Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReSScue trial
2019-004400-35Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Mar 2020
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in systemic sclerosis (SSc) comparing ACHIM infusion arm with Placebo control arm (2 arms). Started Mar 2020; status: completed.
02
Drugs
anaerobically cultivated human intestinal microbiota
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2019-004400-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004400-35.